BioAge Labs Inc.
BIOAHealthcare|Biotechnology|US
$5.34
-0.20 (-3.61%)
DCF Value
$8.93
Tangible Book / Share
$7.55
Cash / Share
$6.18
Ownership Breakdown
84.1%
Float
37.6M
Shares Outstanding
31.7M
Float Shares
Major Holders (16)
Combined: 53.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Kristen Fortney | Individual | 7.20% | 2,704,736 | Feb 13, 2026 | 13D/G |
| Cormorant Asset Management, LP | IA, PN | 5.38% | 2,390,605 | Aug 14, 2026 | 13D/G |
| Bihua Chen | HC, IN | 5.38% | 2,390,605 | Aug 14, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.03% | 2,236,460 | Apr 27, 2026 | 13D/G |
| VK Services, LLC | Other | 4.00% | 1,798,702 | May 15, 2026 | 13D/G |
| Vinod Khosla | Individual | 4.00% | 1,798,702 | May 15, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 3.70% | 1,310,589 | Feb 14, 2025 | 13D/G |
| Peter Kolchinsky | HC, IN | 3.70% | 1,310,589 | Feb 14, 2025 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 3.70% | 1,310,589 | Feb 14, 2025 | 13D/G |
| Khosla Ventures Opportunity I, LP | Partnership | 3.10% | 1,361,550 | May 15, 2026 | 13D/G |
| Khosla Ventures Opportunity Associates I, LLC | Other | 3.10% | 1,361,550 | May 15, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 2.70% | 982,942 | Feb 14, 2025 | 13D/G |
| Khosla Ventures Associates VI, LLC | Other | 1.00% | 437,152 | May 15, 2026 | 13D/G |
| Khosla Ventures VI, LP | Partnership | 1.00% | 437,152 | May 15, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | IA, OO | 0.40% | 135,560 | Feb 17, 2026 | 13D/G |
| Daniel Schneeberger | HC, IN | 0.40% | 135,560 | Feb 17, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,090,617 acquired · 659,806 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | OPTION EX. | 14,198 | $4.38 | $62.2K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | OPTION EX. | 7,861 | $4.38 | $34.4K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | OPTION EX. | 14,198 | $4.38 | $62.2K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | OPTION EX. | 8,958 | $4.30 | $38.5K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | OPTION EX. | 8,958 | $4.30 | $38.5K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | OPTION EX. | 4,065 | $4.30 | $17.5K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | OPTION EX. | 7,261 | $8.39 | $60.9K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | OPTION EX. | 7,861 | $4.38 | $34.4K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | OPTION EX. | 7,261 | $8.39 | $60.9K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | OPTION EX. | 9,301 | $10.85 | $100.9K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | OPTION EX. | 4,000 | $8.39 | $33.6K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | OPTION EX. | 4,290 | $10.85 | $46.5K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | OPTION EX. | 4,065 | $4.30 | $17.5K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | OPTION EX. | 9,301 | $10.85 | $100.9K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | OPTION EX. | 4,000 | $8.39 | $33.6K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | OPTION EX. | 4,290 | $10.85 | $46.5K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 30, 2026 | SELL | 20,216 | $25.19 | $509.2K | Form 4 |
| Barton Shane | Principal Accounting Officer | Jun 29, 2026 | SELL | 42,350 | $25.21 | $1.1M | Form 4 |
| Pande Vijay Satyanand | director | Jun 10, 2026 | AWARD | 22,000 | $15.48 | $340.6K | Form 4 |
| Hemrajani Rekha | director | Jun 10, 2026 | AWARD | 22,000 | $15.48 | $340.6K | Form 4 |
| HEALY JAMES | director | Jun 10, 2026 | AWARD | 22,000 | $15.48 | $340.6K | Form 4 |
| ENRIGHT PATRICK G | director | Jun 10, 2026 | AWARD | 22,000 | $15.48 | $340.6K | Form 4 |
| Davidson Michael H. | director | Jun 10, 2026 | AWARD | 22,000 | $15.48 | $340.6K | Form 4 |
| GARNIER JEAN PIERRE | director | Jun 10, 2026 | AWARD | 22,000 | $15.48 | $340.6K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Apr 23, 2026 | OPTION EX. | 3,542 | $4.38 | $15.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Apr 23, 2026 | OPTION EX. | 3,542 | $4.38 | $15.5K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Apr 1, 2026 | OPTION EX. | 3,383 | $6.57 | $22.2K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Apr 1, 2026 | OPTION EX. | 5,437 | $4.11 | $22.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Apr 1, 2026 | SELL | 8,820 | $17.81 | $157.1K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Apr 1, 2026 | OPTION EX. | 5,437 | $4.11 | $22.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Apr 1, 2026 | OPTION EX. | 3,383 | $6.57 | $22.2K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Mar 2, 2026 | OPTION EX. | 2,000 | $6.57 | $13.1K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Mar 2, 2026 | OPTION EX. | 5,433 | $4.11 | $22.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Mar 2, 2026 | OPTION EX. | 5,433 | $4.11 | $22.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Mar 2, 2026 | OPTION EX. | 2,000 | $6.57 | $13.1K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Mar 2, 2026 | SELL | 7,433 | $20.30 | $150.9K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Mar 1, 2026 | OPTION EX. | 3,542 | $4.38 | $15.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Mar 1, 2026 | OPTION EX. | 3,542 | $4.38 | $15.5K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Feb 17, 2026 | AWARD | 110,000 | $19.63 | $2.2M | Form 4 |
| Morgen Eric | director, officer: Chief Operating Officer | Feb 17, 2026 | AWARD | 110,000 | $19.63 | $2.2M | Form 4 |
| Morgen Eric | director, officer: Chief Operating Officer | Feb 17, 2026 | AWARD | 12,500 | $19.63 | $245.4K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Feb 17, 2026 | AWARD | 110,000 | $19.63 | $2.2M | Form 4 |
| Fortney Kristen | director, officer: Chief Executive Officer | Feb 17, 2026 | AWARD | 330,000 | $19.63 | $6.5M | Form 4 |
| Barton Shane | Principal Accounting Officer | Feb 17, 2026 | AWARD | 45,000 | $19.63 | $883.4K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Feb 2, 2026 | OPTION EX. | 5,433 | $4.11 | $22.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Feb 2, 2026 | OPTION EX. | 2,000 | $6.57 | $13.1K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Feb 2, 2026 | OPTION EX. | 5,433 | $4.11 | $22.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Feb 2, 2026 | OPTION EX. | 2,000 | $6.57 | $13.1K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Feb 2, 2026 | SELL | 7,433 | $18.75 | $139.4K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Feb 1, 2026 | OPTION EX. | 3,541 | $4.38 | $15.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Feb 1, 2026 | OPTION EX. | 3,541 | $4.38 | $15.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Jan 16, 2026 | OPTION EX. | 3,542 | $4.38 | $15.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Jan 16, 2026 | OPTION EX. | 3,542 | $4.38 | $15.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Jan 13, 2026 | OPTION EX. | 27,000 | $8.39 | $226.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Jan 13, 2026 | OPTION EX. | 27,000 | $8.39 | $226.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Jan 13, 2026 | SELL | 8,974 | $18.43 | $165.4K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Jan 13, 2026 | SELL | 4,440 | $19.45 | $86.4K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Jan 13, 2026 | SELL | 11,663 | $20.54 | $239.5K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Jan 13, 2026 | SELL | 1,923 | $21.08 | $40.5K | Form 4 |
| Fortney Kristen | director, officer: Chief Executive Officer | Jan 13, 2026 | SELL | 233,107 | $18.12 | $4.2M | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Jan 2, 2026 | OPTION EX. | 5,433 | $4.11 | $22.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Jan 2, 2026 | OPTION EX. | 2,000 | $6.57 | $13.1K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Jan 2, 2026 | OPTION EX. | 2,000 | $6.57 | $13.1K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Jan 2, 2026 | OPTION EX. | 5,433 | $4.11 | $22.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Jan 2, 2026 | SELL | 7,433 | $12.85 | $95.5K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Dec 9, 2025 | OPTION EX. | 18,000 | $6.57 | $118.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Dec 9, 2025 | OPTION EX. | 18,000 | $6.57 | $118.3K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Dec 9, 2025 | SELL | 18,000 | $12.00 | $216.0K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Dec 4, 2025 | OPTION EX. | 68,897 | $4.11 | $283.2K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Dec 4, 2025 | OPTION EX. | 68,897 | $4.11 | $283.2K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Dec 4, 2025 | SELL | 68,897 | $10.19 | $701.9K | Form 4 |
| Pande Vijay Satyanand | director | Aug 7, 2025 | AWARD | 22,000 | $4.32 | $95.0K | Form 4 |
| Hemrajani Rekha | director | Jun 5, 2025 | AWARD | 22,000 | $4.44 | $97.7K | Form 4 |
| HEALY JAMES | director | Jun 5, 2025 | AWARD | 22,000 | $4.44 | $97.7K | Form 4 |
| ENRIGHT PATRICK G | director | Jun 5, 2025 | AWARD | 22,000 | $4.44 | $97.7K | Form 4 |
| Davidson Michael H. | director | Jun 5, 2025 | AWARD | 22,000 | $4.44 | $97.7K | Form 4 |
| GARNIER JEAN PIERRE | director | Jun 5, 2025 | AWARD | 22,000 | $4.44 | $97.7K | Form 4 |
| Hemrajani Rekha | director | Sep 27, 2024 | BUY | 3,000 | $18.00 | $54.0K | Form 4 |
| Barton Shane | Principal Accounting Officer | Sep 27, 2024 | BUY | 2,632 | $18.00 | $47.4K | Form 4 |
| Morgen Eric | director, officer: Chief Operating Officer | Feb 18, 2025 | AWARD | 25,000 | $4.38 | $109.5K | Form 4 |
| RUBIN PAUL D | Chief Medical Officer | Feb 18, 2025 | AWARD | 200,000 | $4.38 | $876.0K | Form 4 |
| Morgen Eric | director, officer: Chief Operating Officer | Feb 18, 2025 | AWARD | 200,000 | $4.38 | $876.0K | Form 4 |
| GOLDSTEIN DOV A MD | Chief Financial Officer | Feb 18, 2025 | AWARD | 170,000 | $4.38 | $744.6K | Form 4 |
| Fortney Kristen | director, officer: Chief Executive Officer | Feb 18, 2025 | AWARD | 530,000 | $4.38 | $2.3M | Form 4 |
| Barton Shane | Principal Accounting Officer | Feb 18, 2025 | AWARD | 90,000 | $4.38 | $394.2K | Form 4 |
| Barton Shane | Principal Accounting Officer | Dec 18, 2024 | AWARD | 40,000 | $4.30 | $172.0K | Form 4 |
| Pande Vijay Satyanand | director | Oct 3, 2024 | BUY | 25,306 | $19.90 | $503.6K | Form 4 |
| Pande Vijay Satyanand | director | Oct 2, 2024 | BUY | 67,096 | $19.73 | $1.3M | Form 4 |
| Pande Vijay Satyanand | director | Oct 1, 2024 | BUY | 126,793 | $19.73 | $2.5M | Form 4 |
| Cormorant Asset Management, LP | other: Former 10% Owner | Sep 27, 2024 | BUY | 450,000 | $18.00 | $8.1M | Form 4 |
| Cormorant Asset Management, LP | other: Former 10% Owner | Sep 27, 2024 | CONVERSION | 1,179,529 | — | — | Form 4 |
| Cormorant Asset Management, LP | other: Former 10% Owner | Sep 27, 2024 | CONVERSION | 5,263,772 | — | — | Form 4 |
| Pande Vijay Satyanand | director | Sep 27, 2024 | CONVERSION | 413,100 | — | — | Form 4 |
| Pande Vijay Satyanand | director | Sep 27, 2024 | BUY | 900,000 | $18.00 | $16.2M | Form 4 |
| Pande Vijay Satyanand | director | Sep 27, 2024 | CONVERSION | 855,972 | — | — | Form 4 |
| Pande Vijay Satyanand | director | Sep 27, 2024 | CONVERSION | 655,294 | — | — | Form 4 |
| Pande Vijay Satyanand | director | Sep 27, 2024 | CONVERSION | 189,609 | — | — | Form 4 |
| Pande Vijay Satyanand | director | Sep 27, 2024 | CONVERSION | 2,924,318 | — | — | Form 4 |
| Pande Vijay Satyanand | director | Sep 27, 2024 | CONVERSION | 3,819,863 | — | — | Form 4 |
| Pande Vijay Satyanand | director | Sep 27, 2024 | CONVERSION | 1,843,502 | — | — | Form 4 |